Artwork

Content provided by Manhattan Institute. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Manhattan Institute or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Covid-19: Regulatory Obstacles to U.S. Recovery

26:52
 
Share
 

Manage episode 261744000 series 62998
Content provided by Manhattan Institute. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Manhattan Institute or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

James R. Copland joins Brian Anderson to discuss how America's uniquely cumbersome regulatory system impeded the national response to the Covid-19 crisis and how costly litigation could damage the economy even further.

The FDA and CDC's administrative failings in the early days of the crisis proved costly. The federal process for reviewing and approving drugs and medical devices, writes Copland, still leaves much to be desired. And a wave of coronavirus-related lawsuits poses a serious threat to future business viability.

  continue reading

368 episodes

Artwork
iconShare
 
Manage episode 261744000 series 62998
Content provided by Manhattan Institute. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Manhattan Institute or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

James R. Copland joins Brian Anderson to discuss how America's uniquely cumbersome regulatory system impeded the national response to the Covid-19 crisis and how costly litigation could damage the economy even further.

The FDA and CDC's administrative failings in the early days of the crisis proved costly. The federal process for reviewing and approving drugs and medical devices, writes Copland, still leaves much to be desired. And a wave of coronavirus-related lawsuits poses a serious threat to future business viability.

  continue reading

368 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide